experiments were as follows: H0.13.4 (7), anti-Thy 1.2; AD4(15) (8) , anti-Lyt 2.2; GK 1.5 (9), anti-L3T4; CT-1 (10), anti-CT; and J1 ld (11) , antilymphocyte.
Isolation oflEL. Procedures used to isolate intestinal IEL have been previously described (12) . These consist of an EDTA-extraction of the intestinal epithelium and IEL, followed by density gradient separations on Percotl (1) . As determined from paraffinembedded tissue sections, this procedure permits isolation of IEL without penetration into the lamina propria layer.
Flow Cytometry Analysis of Cell Surface Antigens. Analyses of lymphocyte surface markers
were done by indirect immunofluorescence, using the primary mAb listed above, followed by FITC-conjugated rabbit anti-mouse or rabbit anti-rat immunoglobulin. Stained cells were analyzed on an Ortho Cytofluorograph, system 50-H (Ortho Diagnostics, Westwood, MA).
Assay for Cytotoxic Activity. Percoll-passed IEL effector cells and dilutions were added in 100 tA to 96-well microtiter plates. 5ZCr-labelled target cells (P815 or YAC-1) were added to effector cells in 100 t~l at a final concentration of 104 targets cells/well. Cultures were incubated for 4 h at 37°C in 5% COe. Complement-mediated depletion of IEL subsets was done by incubating 20-30 x 106 IEL with monoclonal anti-CT (1/100 dilution of ascites) or anti-J 11 d (undiluted tissue culture supernatant) for 45 min at 4 o C, followed by rabbit complement (l/10 dilution) at 37 °C for 45 min. Treated IEL were passed through Ficoll-Hypaque, and viable cells were assayed for cytotoxic activity. Specific lyses were determined as follows: percent specific lysis = 100 x [cpm release experimental group) -(cpm spontaneous release)]/[(cpm after detergent lysis) -(cpm spontaneous release)].
Results

Expression of T Lymphocyte Antigens on Intestinal IEL. Percoll-fractionated IEL
and splenic lymphocytes from unprimed normal and nude mice were studied by flow cytometry analyses for the expression of Thy-1, Lyt-2, L3T4, CT-1, and J1 l d surface antigens. IEL were analyzed on the cell sorter according to small and large cell populations, (Fig. 1) . Small IEL, which were similar in size to resting splenic or lymph node lymphocytes, made up 44% of normal IEL and 38% of nude IEL (Table I) . Large IEL were two to four times the size of small IEL, and comprised 56% of normal and 62% of nude IEL. Small IEL from thymus-bearing mice were predominantly Lyt-2 +, L3T4-lymphocytes, of which about half possessed Thy-I surface antigens. In contrast, 98% of large IEL, although also Lyt-2 + and L3T4-, did not express Thy-1 surface antigens. Thus, nearly 70% of the IEL, overall, were Thy-l-, Lyt-2 +, L3T4-cells. Spleen cells from athymic nude mice were essentially void of Thy-1 + and Lyt-2 + lymphocytes, whereas IEL from nude mice, which were also Thy-l-, were Lyt-2 + for approximately half the cells. The data pertaining to Thy-1 and Lyt-2 expression on IEL correlate with findings of others (1, 2) describing the distribution of those T cell markers on murine IEL, and are important because they indicate that IEL isolates used in the following experiments represent typical IEL populations.
IEL Express a Cytotoxic Activation Antigen and an Antigen Associated with Immature T Cells.
The most surprising findings of these studies pertain to the level of CT and J 1 ld antigen expression on IEL. 50-60% of both large and small IEL from thymus-bearing mice expressed the CT-1 cytotoxic activation antigen. CT-1 antigens were also present on IEL from nude mice to a level equivalent to that found on IEL of thymus-bearing animals. In contrast to the IEL, <3% of spleen cells from thymus-bearing mice were CT-1 +, a finding consistent with other studies (10) of the expression of CT antigens in murine spleen cells of normal unprimed mice. Similarly, in thymus-bearing mice, the majority of large and some small IEL were J1 ld+; in nude mice, roughly half of both small and large IEL were J1 ld +. Since >95% of the large IEL in thymus-bearing mice were Thy-1-cells, J1 ld must be expressed primarily on a Thy-l-, Lyt-2 + IEL population. J l ld antigen expression on unfractionated spleen cells was consistent with that reported by others (11) , and as expected, nearly all splenic lymphocytes from nude mice were J1 ld +.
Natural Effector Activities Present in IEL Isolates are Associated with CT + and
Jl ld + Subsets. To determine whether CT + and J 1 l d ÷ IEL subsets were associated with functional IEL effector populations, fresh IEL isolates were treated with antibody (CT-1 or J 11 d) plus complement before assay for cytotoxic activity against YAC-I (NK-sensitive) and P815 (SC-sensitive) target cells. Both NK and SC cytotoxic activities present in IEL isolates were abrogated by treatment with either CT-1 or J1 I d antibodies (Fig. 2) , indicating that both antigens are associated in some way with cytotoxic effector populations of the IEL. Although J1 ld is specific for nearly all B cells (see Discussion), the finding that J1 ld was expressed on cytotoxic IEL rules out the possibilities that J 11 d + IEL are B cells present in the intestinal epithelium, or that IEL isolates had been contaminated with B cells.
Discussion
The Thy-l-, Lyt-2 + type of IEL constitutes a large proportion (50-70%) of the total IEL, as demonstrated here and as reported by others (1,2, 14) . However, the ontogeny and functional nature of this cell type is a matter of controversy. On the one hand, it has been proposed that those IEL represent thymusindependent cells that have acquired ]ytic activity upon maturation within the intestinal epithelium (3, 4) . Alternatively, the Thy-l-, Lyt-2 + IEL may be derived from peripheral CTL that have lost Thy-1 antigen expression. The finding that more than half of all IEL from unprimed mice express the cytotoxic activation antigen, CT-1, indicates that, as a group, the IEL consist of a population of cytotoxic cells that are highly activated and presumably lytic. Because spleen cells from the same animals used for IEL studies were predominantly CT-I-, similar to what has been reported by others (10) for normal spleen cells, it appears that the intestinal epithelium represents a site uniquely enriched for activated cytotoxic cells. The presence of CT-1 antigens on Thy-l-, Lyt-2 + IEL from thymus-bearing mice (e.g., large IEL) is important in several ways. It shows that CT antigens can be associated with a population of Thy-1-as well as Thy-1 + cytotoxic cells. It also suggests that some effector IEL may represent a thymus-independent type of IEL. However, the data do not formally rule out the possibility that those IEL originated from Thy-1 + peripheral CTL. More convincing evidence of a thymus-independent origin for the Thy-l-, Lyt-2 + IEL comes from the data pertaining to CT antigen expression on nude IEL, where 60-70% of the IEL were CT-1 + and Thy-1-. The presence of Lyt-2 antigens on IEL but not on splenic lymphocytes from nude mice further implicates the intestinal epithelium as a site of local activation of non-thymus-derived cytotoxic precursors. Moreover, the finding that CT-1 antigen is expressed on nude IEL correlates with observations by others (13) that nude IEL possess lyric activity to NK-sensitive target cells.
J1 ld expression on IEL was unexpected, since J1 ld is a murine lymphocyte marker associated with B cells and is not present on mature or activated T cell populations (11) . J1 ld is, however, present on some immature T cells, notably on cortical thymocytes (11) . That J] ld on IEL reflects a T cell marker rather than a B cell marker is suggested in the fbllowing ways. First, it is generally accepted that IEL are essentially void of B cells; <5% of the IEL bear surface Ig (J. R. Klein, unpublished observation, and ref. 14) . Consistent with that fact are the observations in the present study that nearly all IEL were either Lyt-2 + (80-90%) or L3T4 + (6-8%) cells, and as such, J1 ld must be expressed on one or both of those IEL subsets. Second, IEL depleted of J1 ld + cells lost lytic activity mediated by NK and SC effector populations, indicating that J1 ld + IEL were associated with a population of lytically active cells. These findings, which for the first time link J1 l d antigen expression to functional cytotoxic Lyt-2 + cells, although seemingly incompatible with current knowledge ofJ 1 ld expression on lymphocytes, may not be incongruent when considering the biology of the IEL. Rather, the data are taken to indicate that the J1 ld + cell reflects a thymusindependent type of IEL, i.e., an "immature" T cell that has acquired lytic activity within the intestinal epithelium, and has retained the J 1 ld surface marker. This interpretation applies most notably to the large IEL, which are primarily Thy-1-cells. However, when all 1EL were simultaneously stained for Thy-1 and J1 ld antigens using a double staining technique, <5% of the IEL were positive for both Thy-1 and J 11 d antigens (data not shown), suggesting that Thy-1 and J 11 d are distributed on discrete IEL subsets. Thus, by inference, a substantial proportion of the IEL must be Thy-l-, Lyt-2 ÷, L3T4-, J1 ld + cells with lytic activity.
Taken together, the findings reported here suggest that some IEL originate as non-thymus-derived cells that acquire lyric activity presumably within the intestinal epithelium itself. Local activation of effector ceil precursors could occur upon exposure to T cell-derived lymphokines such as IL-2. IL-2 has been shown to induce IEL-derived cytotoxic clones to express NK lytic activity (I 2). Moreover, a mechanism of effector activation such as this would explain recent observations (6) which show that, during an antigen-specific CTL response within the intestinal mucosa, NK and SC cytotoxic activities are simultaneously increased. Finally, it should be noted that the observations described here now can be addressed through molecular studies of T cell receptor gene rearrangements, particularly with respect to the Thy-l-, Lyt-2 ÷, J1 ld + cytotoxic IEL.
Summary
Murine intestinal intraepithelial lymphocytes (IEL) from unprimed thymusbearing and athymic nude mice were characterized according to the expression of murine lymphocyte antigenic markers and cytotoxic activity. The majority of IEL from thymus-bearing mice were Lyt-2 +, L3T4-lymphocytes, over half of which did not express Thy-1 surface antigens. Nude IEL and spleen cells were void of Thy-1 + cells; however, Lyt-2 antigens were expressed on a significant proportion of IEL, but not splenic lymphocytes. Overall, 40-70% of IEL from either thymus-bearing or athymic mice expressed the cytotoxic activation antigen, CT-1, and the J 11 d lymphocyte marker, both of which were associated with a population of Thy-1-, Lyt-2 + cytotoxic IEL. These data are taken to mean that the intestinal epithelium is a site uniquely enriched for activated cytotoxic cells, a significant proportion of which originate as non-thymus-derived lymphocytes with acquired lytic activity.
